IL6 and systemic sclerosis: Subclinical atherosclerosis plaque occurrence in SSc patients was reported to be associated with smoking, higher blood pressure, impaired kidney function, high levels of IL-6, serum levels of vascular cell adhesion molecule 1 and with ACA [22].